Conventional medical therapy in heart failure patients eligible for the PARADIGM-HF, DAPA-HF, and SHIFT trials-Reference-Cited by-同舟云学术

Conventional medical therapy in heart failure patients eligible for the PARADIGM-HF, DAPA-HF, and SHIFT trials

Published:2022-07 Issue: Volume:359 Page:76-83
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Shoji Satoshi,Kohsaka Shun,Shiraishi Yasuyuki,Kohno Takashi,Sawano Mitsuaki,Ikemura Nobuhiro,Niimi Nozomi,Nagatomo Yuji,Tanaka Toshikazu D.,Takei Makoto,Ono Tomohiko,Sakamoto Munehisa,Nakano Shintaro,Nakamura Iwao,Inoue Soushin,Fukuda Keiichi,Yoshikawa Tsutomu

Funder

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference45 articles.

1. ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure;Yancy;J. Am. Coll. Cardiol.,2017

2. Effects of enalapril on mortality in severe congestive heart failure;CONSENSUS Trial Study Group;N. Engl. J. Med.,1987

3. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure;Packer;N. Engl. J. Med.,1996

4. The effect of spironolactone on morbidity and mortality in patients with severe heart failure;Pitt;N. Engl. J. Med.,1999

5. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure;McMurray;N. Engl. J. Med.,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale and protocol of the LAQUA-HF trial: a factorial randomised controlled trial evaluating the effects of neurohormonal and diuretic agents on health-status reported outcomes in heart failure patients;BMJ Open;2024-02

2. Implementation of evidence-based heart failure management: Regional variations between Japan and the USA;Journal of Cardiology;2024-02